CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- Open-market buys, last 90 days
- $120,435
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$120,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-10 | Kim Jiny Director | Grant or award · Stock Option (right to buy) | +18,975 | 18,975 | ||
| 2022-08-10 | Jones Edward Raymond Director | Grant or award · Stock Option (right to buy) | +18,975 | 18,975 | ||
| 2022-08-10 | BATOR MICHAEL G. Director | Grant or award · Stock Option (right to buy) | +18,975 | 18,975 | ||
| 2022-08-10 | Kraus Al Director | Grant or award · Stock Option (right to buy) | +37,950 | 37,950 | ||
| 2022-08-10 | Deliargyris Efthymios Chief Medical Officer | Grant or award | +55,000 | 228,384 | ||
| 2022-08-10 | Deliargyris Efthymios Chief Medical Officer | Grant or award | +52,000 | 283,384 | ||
| 2022-08-10 | Deliargyris Efthymios Chief Medical Officer | Grant or award · Stock Option (right to buy) | +74,000 | 74,000 | ||
| 2022-08-10 | Deliargyris Efthymios Chief Medical Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2022-08-10 | Capponi Vincent President and COO | Grant or award | +69,000 | 512,545 | ||
| 2022-08-10 | Capponi Vincent President and COO | Grant or award · Stock Option (right to buy) | +86,000 | 86,000 | ||
| 2022-08-10 | Capponi Vincent President and COO | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2022-08-10 | BLOCH KATHLEEN P. Chief Financial Officer | Grant or award | +55,500 | 405,161 | ||
| 2022-08-10 | BLOCH KATHLEEN P. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2022-08-10 | BLOCH KATHLEEN P. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +215,000 | 215,000 | ||
| 2022-08-10 | Chan Phillip P. Chief Executive Officer | Grant or award | +79,000 | 845,130 | ||
| 2022-08-10 | Chan Phillip P. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +106,000 | 106,000 | ||
| 2022-08-10 | Chan Phillip P. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +240,000 | 240,000 | ||
| 2022-06-21 | Capponi Vincent President and COO | Purchase | +2,000 | $1.80 | $4K | 443,545 |
| 2022-06-16 | Capponi Vincent See Remarks | Purchase | +3,000 | $2.00 | $6K | 441,545 |
| 2022-06-16 | Chan Phillip P. Chief Executive Officer | Purchase | +2,221 | $1.85 | $4K | 768,351 |
Page 8 of 35 · 698 trades